We identified 3 fecal biomarkers, alpha-2-macroglobulin (A2MG), matrix metalloproteinase-7 (MMP-7), and alpha-1-antitrypsin (A1AT), that were specific to CDI disease status. This evidence concerns the gene A2M and clostridium difficile infection.